vol. 68 February 2026

KOBE Biomedical Innovation Cluster newsletter vol. 68
- February 2026 -

Hello,

Last month, KBIC hosted Regenerative Medicine Industrialization Forum 2026 in Nihonbashi, Tokyo. The aim of this event is to share challenges related to the industrialization of regenerative medicine among Japanese companies and research institutions, strengthening collaboration, and promoting the advancement and industrial development of regenerative medicine.

Under the theme, “Toward the Growth of Regenerative Medicine as an Industry,” leading experts at the forefront of regenerative medicine in Japan and abroad delivered keynote lectures. In addition, a panel discussion brought together representatives from academia, industry, and government to exchange diverse perspectives on the challenges surrounding the industrialization of regenerative medicine. The forum concluded successfully with lively and productive discussions.

Scene from the Seminar

Panel Discussion

Going forward, KBIC will continue to collaborate with domestic and international players to strongly support the growth of Japan’s regenerative medicine industry.

If you missed our past issues of KBIC newsletter, please visit Newsletter Archive.

FBRI Editorial Team

NEWS

CarbGeM Selected as TOP10 Winner of the “Global AI Impact Challenge” at India Government–Hosted AI Impact Summit 2026

CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima,) is pleased to announce that it has been selected as a TOP10 winner in the prestigious Global AI Impact Challenge (AI for ALL)—one of the highest global recognitions for AI innovation—at the AI Impact Summit 2026, an international conference hosted by the Government of India and held in New Delhi from February 16 to 20, 2026.